Literature DB >> 18491211

Usefulness of an early diagnosis for the favorable prognosis of fibrocartilaginous embolism diagnosed by magnetic resonance imaging in 10 small- to middle-sized dogs.

Yuya Nakamoto1, Tsuyoshi Ozawa, Kengo Katakabe, Koichi Nishiya, Tadahisa Mashita, Yutaka Morita, Nobuhiro Yasuda, Yuki Ishii, Munekazu Nakaichi, Kazuhito Itamoto.   

Abstract

Fibrocartilaginous embolism (FCE), a disorder of rapid onset featured by nonprogressive paralysis and paresis of four legs, shows clinical symptoms very similar to those of other disorders, e.g., disk herniation. We examined 10 animals diagnosed with FCE based on clinical symptoms and magnetic resonance imaging (MRI) findings in a retrospective study to examine the relationship between onset-to-diagnosis/treatment initiation time and prognosis of FCE. Statistical procedures, including Fisher's exact probability test, were conducted. All animals in a group, in which the diagnosis was made and treatment was initiated after an elapse of <15 days after onset, showed improved symptoms; the group showed a positive correlation (r = 0.76) between "onset-to-symptom improvement time" and "onset-to-diagnosis/treatment initiation time". Furthermore, the mean onset-to-diagnosis/ treatment initiation times were 2.67 days and 10.25 days in groups without and with sequelae, respectively; the time was significantly (P < 0.02) shorter in the group without sequelae. A significant difference was found between the groups in early diagnosis and treatment initiation. Our study indicates that the early precise diagnosis for acutely developed paralysis and paresis of four legs through testings including MRI, as well as the early onset of their treatment are important to obtain a favorable prognosis.

Entities:  

Mesh:

Year:  2008        PMID: 18491211     DOI: 10.1007/s11259-008-9061-y

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  13 in total

1.  Fatal nucleus pulposus embolism of spinal cord after trauma.

Authors:  J L NAIMAN; W L DONOHUE; J S PRICHARD
Journal:  Neurology       Date:  1961-01       Impact factor: 9.910

Review 2.  Fibrocartilaginous emboli.

Authors:  T M Neer
Journal:  Vet Clin North Am Small Anim Pract       Date:  1992-07       Impact factor: 2.093

3.  Necrotizing myelopathy in a cat.

Authors:  F A Zaki; R G Prata; L L Werner
Journal:  J Am Vet Med Assoc       Date:  1976-07-15       Impact factor: 1.936

4.  Ischemic myelopathy caused by fibrocartilaginous emboli in a horse.

Authors:  H W Taylor; M Vandevelde; E C Firth
Journal:  Vet Pathol       Date:  1977-09       Impact factor: 2.221

Review 5.  Fibrocartilaginous embolism in dogs.

Authors:  L Cauzinille
Journal:  Vet Clin North Am Small Anim Pract       Date:  2000-01       Impact factor: 2.093

6.  Fibrocartilaginous embolism in 75 dogs: clinical findings and factors influencing the recovery rate.

Authors:  G Gandini; S Cizinauskas; J Lang; R Fatzer; A Jaggy
Journal:  J Small Anim Pract       Date:  2003-02       Impact factor: 1.522

7.  Spinal cord infarction due to emboli arising from the intervertebral discs in the dog.

Authors:  I R Griffiths
Journal:  J Comp Pathol       Date:  1973-04       Impact factor: 1.311

8.  Fibrocartilaginous embolization to the spinal cord: serial MR imaging monitoring and pathologic study.

Authors:  Thierry P Duprez; Leslie Danvoye; Danielle Hernalsteen; Guy Cosnard; Christian J Sindic; Catherine Godfraind
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

9.  Fibrocartilaginous embolism in a chondrodystrophoid breed dog.

Authors:  H Ueno; J Shimizu; Y Uzuka; Y Kobayashi; H Hirokawa; E Ueno; A Suzuki; K Yamada
Journal:  Aust Vet J       Date:  2005-03       Impact factor: 1.281

10.  Posterior paralysis due to fibrocartilaginous embolism in two weaner pigs.

Authors:  S V Tessaro; C E Doige; C S Rhodes
Journal:  Can J Comp Med       Date:  1983-04
View more
  2 in total

1.  Magnetic resonance imaging muscle lesions in presumptive canine fibrocartilaginous embolic myelopathy.

Authors:  Sabrina M Martens; Stephanie G Nykamp; Fiona M K James
Journal:  Can Vet J       Date:  2018-12       Impact factor: 1.008

2.  Percutaneous transplantation of human umbilical cord-derived mesenchymal stem cells in a dog suspected to have fibrocartilaginous embolic myelopathy.

Authors:  Wook-Hun Chung; Seon-Ah Park; Jae-Hoon Lee; Dai-Jung Chung; Wo-Jong Yang; Eun-Hee Kang; Chi-Bong Choi; Hwa-Seok Chang; Dae-Hyun Kim; Soo-Han Hwang; Hoon Han; Hwi-Yool Kim
Journal:  J Vet Sci       Date:  2013-06-28       Impact factor: 1.672

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.